378 related articles for article (PubMed ID: 26816011)
1. Belatacept and Long-Term Outcomes in Kidney Transplantation.
Vincenti F; Rostaing L; Grinyo J; Rice K; Steinberg S; Gaite L; Moal MC; Mondragon-Ramirez GA; Kothari J; Polinsky MS; Meier-Kriesche HU; Munier S; Larsen CP
N Engl J Med; 2016 Jan; 374(4):333-43. PubMed ID: 26816011
[TBL] [Abstract][Full Text] [Related]
2. Belatacept-versus cyclosporine-based immunosuppression in renal transplant recipients with pre-existing diabetes.
Rostaing L; Neumayer HH; Reyes-Acevedo R; Bresnahan B; Florman S; Vitko S; Heifets M; Xing J; Thomas D; Vincenti F
Clin J Am Soc Nephrol; 2011 Nov; 6(11):2696-704. PubMed ID: 21921152
[TBL] [Abstract][Full Text] [Related]
3. Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study.
Rostaing L; Massari P; Garcia VD; Mancilla-Urrea E; Nainan G; del Carmen Rial M; Steinberg S; Vincenti F; Shi R; Di Russo G; Thomas D; Grinyó J
Clin J Am Soc Nephrol; 2011 Feb; 6(2):430-9. PubMed ID: 21051752
[TBL] [Abstract][Full Text] [Related]
4. Five-year safety and efficacy of belatacept in renal transplantation.
Vincenti F; Blancho G; Durrbach A; Friend P; Grinyo J; Halloran PF; Klempnauer J; Lang P; Larsen CP; Mühlbacher F; Nashan B; Soulillou JP; Vanrenterghem Y; Wekerle T; Agarwal M; Gujrathi S; Shen J; Shi R; Townsend R; Charpentier B
J Am Soc Nephrol; 2010 Sep; 21(9):1587-96. PubMed ID: 20634298
[TBL] [Abstract][Full Text] [Related]
5. Obesity is associated with a higher incidence of rejection in patients on belatacept: A pooled analysis from the BENEFIT/BENEFIT-EXT clinical trials.
Lange NW; King K; Husain SA; Salerno DM; Tsapepas DS; Hedvat J; Yu M; Mohan S
Am J Transplant; 2024 Jun; 24(6):1027-1034. PubMed ID: 38387620
[TBL] [Abstract][Full Text] [Related]
6. Use of a Belatacept-based Immunosuppression for Kidney Transplantation From Donors After Circulatory Death: A Paired Kidney Analysis.
Eid R; Scemla A; Giral M; Arzouk N; Bertrand D; Peraldi MN; Mesnard L; Longuet H; Maanaoui M; Desbuissons G; Lefevre E; Snanoudj R
Transplant Direct; 2024 May; 10(5):e1615. PubMed ID: 38617465
[TBL] [Abstract][Full Text] [Related]
7. Three-year Outcomes After Conversion From Monthly to Every 2-month Belatacept Maintenance Therapy in Kidney Transplant Recipients: Results From a Randomized Controlled Trial.
Johnson AC; Karadkhele GM; Shenvi N; Easley KA; Larsen CP; Badell IR
Transplant Direct; 2023 Mar; 9(3):e1449. PubMed ID: 36875938
[TBL] [Abstract][Full Text] [Related]
8. Converting Maintenance Kidney-Transplant Patients From Belatacept to Another Immunosuppressive Regimen: A Cautionary Tale.
Chandran S; Wojciechowski D
Kidney Int Rep; 2020 Dec; 5(12):2123-2124. PubMed ID: 33306045
[No Abstract] [Full Text] [Related]
9. Belatacept: A worthy alternative to cyclosporine?
Melvin G; Sandhiya S; Subraja K
J Pharmacol Pharmacother; 2012 Jan; 3(1):90-2. PubMed ID: 22368437
[No Abstract] [Full Text] [Related]
10. Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study.
Durrbach A; Pestana JM; Florman S; Del Carmen Rial M; Rostaing L; Kuypers D; Matas A; Wekerle T; Polinsky M; Meier-Kriesche HU; Munier S; Grinyó JM
Am J Transplant; 2016 Nov; 16(11):3192-3201. PubMed ID: 27130868
[TBL] [Abstract][Full Text] [Related]
11. The Clearer BENEFITS of Belatacept.
Heher E; Markmann JF
N Engl J Med; 2016 Jan; 374(4):388-9. PubMed ID: 26816017
[No Abstract] [Full Text] [Related]
12. Belatacept and Long-Term Outcomes in Kidney Transplantation.
N Engl J Med; 2016 Feb; 374(7):698. PubMed ID: 26886546
[No Abstract] [Full Text] [Related]
13. Belatacept and Long-Term Outcomes in Kidney Transplantation.
Vincenti F
N Engl J Med; 2016 Jun; 374(26):2600-1. PubMed ID: 27355541
[No Abstract] [Full Text] [Related]
14. Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial.
Grinyó JM; Del Carmen Rial M; Alberu J; Steinberg SM; Manfro RC; Nainan G; Vincenti F; Jones-Burton C; Kamar N
Am J Kidney Dis; 2017 May; 69(5):587-594. PubMed ID: 27889299
[TBL] [Abstract][Full Text] [Related]
15. A Randomized Controlled Clinical Trial Comparing Belatacept With Tacrolimus After De Novo Kidney Transplantation.
de Graav GN; Baan CC; Clahsen-van Groningen MC; Kraaijeveld R; Dieterich M; Verschoor W; von der Thusen JH; Roelen DL; Cadogan M; van de Wetering J; van Rosmalen J; Weimar W; Hesselink DA
Transplantation; 2017 Oct; 101(10):2571-2581. PubMed ID: 28403127
[TBL] [Abstract][Full Text] [Related]
16. Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.
Peyvandi F; Scully M; Kremer Hovinga JA; Cataland S; Knöbl P; Wu H; Artoni A; Westwood JP; Mansouri Taleghani M; Jilma B; Callewaert F; Ulrichts H; Duby C; Tersago D;
N Engl J Med; 2016 Feb; 374(6):511-22. PubMed ID: 26863353
[TBL] [Abstract][Full Text] [Related]
17. Belatacept and Long-Term Outcomes in Kidney Transplantation.
Riella LV; Gabardi S; Azzi J
N Engl J Med; 2016 Jun; 374(26):2599-600. PubMed ID: 27355545
[No Abstract] [Full Text] [Related]
18. Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients.
Wen X; Casey MJ; Santos AH; Hartzema A; Womer KL
Am J Transplant; 2016 Nov; 16(11):3202-3211. PubMed ID: 27137884
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
Kernan WN; Viscoli CM; Furie KL; Young LH; Inzucchi SE; Gorman M; Guarino PD; Lovejoy AM; Peduzzi PN; Conwit R; Brass LM; Schwartz GG; Adams HP; Berger L; Carolei A; Clark W; Coull B; Ford GA; Kleindorfer D; O'Leary JR; Parsons MW; Ringleb P; Sen S; Spence JD; Tanne D; Wang D; Winder TR;
N Engl J Med; 2016 Apr; 374(14):1321-31. PubMed ID: 26886418
[TBL] [Abstract][Full Text] [Related]
20. Routine Amoxicillin for Uncomplicated Severe Acute Malnutrition in Children.
Isanaka S; Langendorf C; Berthé F; Gnegne S; Li N; Ousmane N; Harouna S; Hassane H; Schaefer M; Adehossi E; Grais RF
N Engl J Med; 2016 Feb; 374(5):444-53. PubMed ID: 26840134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
